Non-steroidal aromatase inhibitors based on a biphenyl scaffold: Synthesis, in vitro SAR, and molecular modelling

被引:32
作者
Jackson, Toby [1 ,2 ]
Woo, L. W. Lawrence [1 ,2 ]
Trusselle, Melanie N. [1 ,2 ]
Purohit, Atul [3 ]
Reed, Michael J. [3 ]
Potter, Barry V. L. [1 ,2 ]
机构
[1] Univ Bath, Sterix Ltd, Bath BA2 7AY, Avon, England
[2] Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[3] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Fac Med, Sterix Ltd, London W2 1NY, England
关键词
aromatase inhibitors; biphenyls; breast cancer; endocrine therapy; triazoles;
D O I
10.1002/cmdc.200700266
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and in vitro biological evaluation (JEG-3 cells) of a series of novel and potent aromatose inhibitors, prepared by microwave-enhanced Suzuki cross-coupling methodology, are reported. These compounds possess a biphenyl template incorporated with the haem-ligating triazolylmethyl moiety, either on its own or in combination with other substituent(s) at various positions on the phenyl rings. The most potent aromatase inhibitor reported herein has an IC50 value of 0.12 nM, although seven of its congeners are also highly potent (IC50 <= 0.5 nM). They all bear the (5-triazolylmethyl-2-cyano)biphenyl structural motif Docking of representative compounds into a homology model of human aromatase assists in the rationalisation of the SAR derived from the in vitro biological results and supports a crucial role for a cyano group on the "A" phenyl ring, which is accessible to hydrogen bond interactions with Ser478. Further development of these compounds as potential therapeutic agents for the treatment of hormone-dependent breast cancer is warranted given the high level of potency observed for this class of aromatase inhibitor in vitro.
引用
收藏
页码:603 / 618
页数:16
相关论文
共 31 条
[21]   A new class of nonsteroidal aromatase inhibitors:: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase [J].
Recanatini, M ;
Bisi, A ;
Cavalli, A ;
Belluti, F ;
Gobbi, S ;
Rampa, A ;
Valenti, P ;
Palzer, M ;
Palusczak, A ;
Hartmann, RW .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :672-680
[22]   Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: Synthesis and biological evaluation [J].
Saberi, MR ;
Vinh, TK ;
Yee, SW ;
Griffiths, BJN ;
Evans, PJ ;
Simons, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (03) :1016-1022
[23]  
Thürlimann B, 2005, NEW ENGL J MED, V353, P2747
[24]  
*TRIP INC, SYBYL 7 1
[25]   Investigations into the Suzuki-Miyaura coupling aiming at multikilogram synthesis of E2040 using (o-cyanophenyl)boronic esters [J].
Urawa, Y ;
Naka, H ;
Miyazawa, M ;
Souda, S ;
Ogura, K .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2002, 653 (1-2) :269-278
[26]   Imidazole substituted biphenyls: A new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer [J].
Wachall, BG ;
Hector, M ;
Zhuang, Y ;
Hartmann, RW .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (09) :1913-1924
[27]   Crystal structure of human cytochrome P4502C9 with bound warfarin [J].
Williams, PA ;
Cosme, J ;
Ward, A ;
Angova, HC ;
Vinkovic, DM ;
Jhoti, H .
NATURE, 2003, 424 (6947) :464-468
[28]   Dual aromatase-steroid sulfatase inhibitors [J].
Woo, L. W. Lawrence ;
Bubert, Christian ;
Sutcliffe, Oliver B. ;
Smith, Andrew ;
Chander, Surinder K. ;
Mahon, Mary F. ;
Purohit, Atul ;
Reed, Michael J. ;
Potter, Barry V. L. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (15) :3540-3560
[29]  
Woo LWL, 2005, CRC ENZYM INHIB SER, P221
[30]   A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activity [J].
Wood, PM ;
Woo, LWL ;
Humphreys, A ;
Chander, SK ;
Purohit, A ;
Reed, MJ ;
Potter, BVL .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 94 (1-3) :123-130